Latest Regulatory News

Pacific Nickel Mines is pressing ahead with the sale of its Kolosori Nickel Project for a nominal A$1 while remaining suspended from the ASX, supported by ongoing Glencore financing and subject to key approvals.

CleanSpace Holdings expects modest revenue growth for FY26, hindered by product certification delays and global market challenges, while maintaining a strong cash position and preparing a new respirator launch.

Aguia Resources has received official commercialisation approval for its Pampafos phosphate fertiliser project, enabling invoicing and marketing ahead of a targeted sales campaign designed to boost cash flow by mid-2026.

Bio-Gene Technology has raised A$3.21 million to complete critical safety studies for its novel insecticide Flavocide and ramp up production of its natural insecticide Qcide, advancing its path to commercialisation in multiple global markets.

Green Technology Metals (ASX: GT1) is pushing forward its Seymour lithium project with an $11 million recapitalisation underway and fresh additions of tantalum and rubidium processing streams aimed at boosting project economics.

ASX Limited projects a significant 18-21% rise in expenses for FY27 driven by technology modernisation and regulatory response, while increasing capital expenditure guidance to up to $200 million.

Boab Metals has sealed a $109 million EPC contract with GR Engineering to refurbish and relocate the DeGrussa processing plant to its Sorby Hills project, aiming for concentrate production by mid-2027.

Thrive Tribe Technologies (ASX:1TT) has locked in A$4 million through a share placement to accelerate its AI-enabled workforce engagement software, targeting enterprise and defence sectors.

Brightstar Resources has given the green light to its Goldfields Project, commencing construction of a 1.5Mtpa processing plant at Laverton. First gold production is slated for June 2027, backed by full funding and regulatory approvals.

Strickland Metals has expanded the Gradina Deposit's inferred gold resource by 600,000 ounces, pushing the Rogozna Project's total resource to 9.24 million ounces gold equivalent and reinforcing its Tier-1 status.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.

Solis Minerals is poised to launch diamond drilling at its Mandacaru lithium prospect in Brazil this June, backed by robust geochemical data and expert technical support. Meanwhile, its Cinto Copper Project in Peru has secured final drilling approvals, marking a significant step in the company’s 2026 exploration campaign.